Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/245751
DC FieldValue
dc.titleRisk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients
dc.contributor.authorHuang, Y
dc.contributor.authorSoon, YY
dc.contributor.authorAminkeng, F
dc.contributor.authorTay, SH
dc.contributor.authorAng, Y
dc.contributor.authorGoh, BC
dc.contributor.authorWong, A
dc.contributor.authorSoo, RA
dc.date.accessioned2023-11-06T07:01:21Z
dc.date.available2023-11-06T07:01:21Z
dc.date.issued2021-03
dc.identifier.citationHuang, Y, Soon, YY, Aminkeng, F, Tay, SH, Ang, Y, Goh, BC, Wong, A, Soo, RA (2021-03). Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients 16 (3) : S577-S577. ScholarBank@NUS Repository.
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/245751
dc.publisherELSEVIER SCIENCE INC
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.subjectRespiratory System
dc.subjectImmune-related adverse events
dc.subjectrisk factors
dc.subjectImmune checkpoint inhibitors
dc.typeConference Paper
dc.date.updated2023-11-06T02:11:06Z
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.contributor.departmentMEDICINE
dc.description.volume16
dc.description.issue3
dc.description.pageS577-S577
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Intl Journal of Cancer - 2021 - Huang - Risk factors for immune‐related adverse events from anti‐PD‐1 or anti‐PD‐L1.pdf755.74 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.